Shopping cart imageShopping Cart (0) Items

Contrave, Qsymia or Belviq: Which is the Best New FDA Approved Weight Loss Medication?

Contrave, Qsymia or Belviq: Which is the Best New FDA Approved Weight Loss Medication? cover image
Contrave, Qsymia or Belviq: Which is the Best New FDA Approved Weight Loss Medication? cover image Contrave, Qsymia or Belviq: Which is the Best New FDA Approved Weight Loss Medication? cover image Contrave, Qsymia or Belviq: Which is the Best New FDA Approved Weight Loss Medication? cover image
Click images to enlarge
by: richard lipman
Books with a 0 star rating  (0)
Publication Date: May 12, 2015
Book Size: 5.5" x 8.5"
Pages: 74
Binding: Perfect Bound
$14.95

Usually prints within 3 - 5 business days
Book Synopsis
Endocrinologist and weight loss specialist Richard Lipman M.D. has treated thousands of overweight and obese patients in his Miami Florida office with many weight loss plans and medications. In this booklet he reviews three new, ground breaking weight loss medications released by the FDA over the past two years- Contrave, Qsymia and Belviq. He outlines the efficacy, safety, side effects and his experience treating hundreds of patients with these medications. Contrave, Qsymia, and Belviq each have entirely different mechanisms of action, weight loss efficiency, and side effects, allowing you to individualize your weight loss experience by enhancing the benefits while minimizing the side effects. If you have 20, 30, 50, or even 100 pounds or more to lose, like 100 million other Americans, these medications may be for you. Dr Lipman reviews what would be the best choice of medications depending on your life style, weight, medical problems and eating patterns
Customer Comments
Be the first to write a comment and rate this book
Other Books By This Author